CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Restricted dietary protein +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06263725
NCT06263725N/ACompleted

Protein Restriction (PR) for Weight Loss

University of Copenhagen·interventional·Posted Feb 16, 2024·Updated Feb 16, 2024

In Brief

A clinical study evaluating Restricted dietary protein and Habitual diet for Diet, Healthy, Body Weight. Completed, enrolled 15 participants across 1 site.

Detailed Summary

Prolonged dietary protein restriction has been shown to increase energy expenditure in mice simultaneously with an increase in plasma FGF21 levels. In overfeeding studies, a protein-restricted diet reduces weight gain in both mice and humans compared with normal and high-protein diets. Further, in energy balance studies, when lean men are provided with a protein-restricted diet for five weeks, an increase in energy intake was necessary to obtain their body weight. However, whether the effect of a protein-restricted diet is the same when consumed by overweight to obese men has divergent results in both mice and humans.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 16, 2024
Enrollment StartOct 1, 2021
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 2.4 years ago

Interventions

Restricted dietary proteinother

Participants will be allocated to 5 week isocaloric restricted protein intake

Habitual dietother

Participants will be follow their habitual, high protein intake